An FDA Science Board subcommittee will look for ways to strengthen regulatory systems in emerging economies.
A new FDA Science Board subcommittee will work to "generate some enthusiasm and some momentum" outside FDA for strengthening regulatory systems in developing countries, according to the panel's chair.
The Global Health Subcommittee, formed in April, will assess the level of safety awareness in countries exporting food and medical...
The exemption, which President Donald Trump announced on July 17, is intended to cut the risk of critical device shortages. Stakeholders say the technology needed to cut emissions to required levels is not yet widely available.
Dexcom has recalled several models of its glucose monitoring receivers due to a speaker glitch that may suppress vital blood sugar alerts. The FDA designated the recall, which affects thousands of devices, as class I.
A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.
